AbbVie Inc.
ABBV
$217.80
$3.301.54%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -45.96% | 8,354.55% | -88.08% | -31.53% | -6.06% |
| Total Depreciation and Amortization | -5.05% | -5.47% | -0.77% | -3.80% | -1.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 250.56% | -64.81% | 233.21% | 26.72% | 154.29% |
| Change in Net Operating Assets | 25.50% | -19.14% | 67.07% | 83.38% | -1,144.53% |
| Cash from Operations | 134.19% | -25.96% | 28.95% | 126.90% | -59.53% |
| Capital Expenditure | -12.77% | -13.06% | -53.01% | -11.62% | -21.76% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 50.56% | 35.21% | 67.01% | -11.51% | 94.27% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -213.16% | -87.08% | -116.67% | 255.56% | 733.33% |
| Cash from Investing | 21.90% | 21.93% | 60.47% | -7.17% | 92.33% |
| Total Debt Issued | 43.03% | -125.00% | -- | -- | -72.02% |
| Total Debt Repaid | 17.42% | 86.13% | -400.25% | -12.13% | 40.76% |
| Issuance of Common Stock | -- | 380.00% | -5.97% | -50.00% | -- |
| Repurchase of Common Stock | -54.94% | 99.16% | 76.47% | -33.33% | 27.42% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.50% | -5.78% | -5.82% | -5.82% | -5.52% |
| Other Financing Activities | -97.01% | -200.00% | 15.63% | -- | 189.33% |
| Cash from Financing | 173.05% | 39.28% | -49.41% | 55.55% | -111.63% |
| Foreign Exchange rate Adjustments | -233.33% | 123.91% | -200.00% | 433.33% | 150.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,292.55% | 76.92% | 85.73% | 126.17% | -106.64% |